Inactivation of the p15(INK4B) and p16(INK4) genes in hematologic malignancies

被引:20
作者
Heyman, M [1 ]
Einhorn, S [1 ]
机构
[1] KAROLINSKA HOSP,RADIUMHEMMET,S-17176 STOCKHOLM,SWEDEN
关键词
p16; p15; CDKN2; CDKN2B; ALL; leukemia; lymphoma;
D O I
10.3109/10428199609054826
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The recently discovered p15(INK4B),d p16(INK4) genes encoding cell cycle regulating proteins, map to a region on chromosome 9p21 that is commonly deleted in a variety of malignant diseases. The p16(INK4) gene has now been shown to be a tumor suppressor gene. It is frequently inactivated in cancer and is possibly the second most often mutated gene in human malignant disease after p53. The role of the p15(INK4B) and p16(INK4) genes in hematologic malignancies has been the subject of intense investigation since their discovery. In this review we address the function and possible role in tumorigenesis of the p15(INK4B) and p16(INK4) genes and discuss their significance as prognostic markers in hematologic malignancies.
引用
收藏
页码:235 / 245
页数:11
相关论文
共 161 条
[1]  
ARAP W, 1995, CANCER RES, V55, P1351
[2]  
ARTHUR DC, 1982, BLOOD, V59, P96
[3]   CHROMOSOME-9P AND HEREDITARY CUTANEOUS MALIGNANT-MELANOMA [J].
BALE, SJ ;
DRACOPOLI, NC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (01) :70-70
[4]   FREQUENT MUTATIONS OF CDKN2 IN PRIMARY PANCREATIC ADENOCARCINOMAS [J].
BARTSCH, D ;
SHEVLIN, DW ;
TUNG, WS ;
KISKER, O ;
WELLS, SA ;
GOODFELLOW, PJ .
GENES CHROMOSOMES & CANCER, 1995, 14 (03) :189-195
[5]   INVOLVEMENT OF 9P IN METASTATIC OVARIAN ADENOCARCINOMAS [J].
BELLO, MJ ;
MORENO, S ;
REY, JA .
CANCER GENETICS AND CYTOGENETICS, 1990, 45 (02) :223-229
[6]   CHROMOSOME-ABERRATIONS IN METASTATIC OVARIAN-CANCER - RELATIONSHIP WITH ABNORMALITIES IN PRIMARY TUMORS [J].
BELLO, MJ ;
REY, JA .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) :50-54
[7]  
BELTINGER CP, 1995, CANCER RES, V55, P2053
[8]   INFREQUENT CDKN2 (MTS1/P16) GENE ALTERATIONS IN HUMAN PRIMARY BREAST-CANCER [J].
BERNS, EMJJ ;
KLIJN, JGM ;
SMID, M ;
VANSTAVEREN, IL ;
GRUIS, NA ;
FOEKENS, JA .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :964-967
[9]  
BRANDTER LB, 1996, IN PRESS EUR J HAEMA
[10]  
BRENNER AJ, 1995, CANCER RES, V55, P2892